Page 359 - IJB-9-3
P. 359

International Journal of Bioprinting                     Decellularized  materials for bioprinting of liver constructs



            functionally  innovative  biomaterials  and  drug  delivery   Author contributions
            media must be explored to bridge the gap between   Conceptualization: Tanveer Ahmad Mir
            experimental research and practical personalized   Supervision: Tanveer Ahmad Mir
            regenerative medicine applications. Thus, further advances   Visualization: Shadil Ibrahim Wani, Alaa Alzhrani, Kenichi
            are urgently needed to solve the challenging problems   Arai, Bilal Ahmed Mir, Shadab Kazmi
            associated with the multiscale manufacturing of clinical-  Writing – original draft:  Tanveer  Ahmad  Mir,  Makoto
            grade bioengineered products for application in tissue   Nakamura, Shinji Sakai, Shintaroh Iwanaga
            repair and regeneration [150] . Furthermore, the current   Writing – review & editing: Abdullah M. Assiri, Dieter C.
            intrinsic shortcomings of bioprinting technologies, which   Broering
            are essential for reconstructing vascularized, hierarchical
            biological structures with organ-specific biochemical   All authors have given approval for the final version of
            or biomechanical characteristics that resemble their   the draft for submission.
            native counterparts, also need to be addressed through
            interdisciplinary collaborative research efforts.  Ethics approval and consent to participate

            5. Conclusion                                      Not applicable.
            Using bioprinting technology and bioink materials to   Consent for publication
            print and recapitulate tissue/organ function have a broad   Not applicable.
            spectrum of biomedical applications. This automated
            approach has significantly boosted the tissue engineering   Availability of data
            and regenerative medicine research. Despite its remarkable
            advancement and encouraging results, 3D bioprinting   Not applicable.
            technology still needs to be validated to generate fully
            functional and mechanically robust bioprinted liver   References
            substitutes suitable for transplantation. There are
            still  areas  for  improvements  in  using  the  bioprinting   1.   Abouna  GM,  2001,  The  humanitarian  aspects  of  organ
            approach for clinical applications. Further advancements,   transplantation. Transpl Intl, 14:117–123.
            including  advances  in  the  printing  resolution,  and  the   https://doi.org/10.1007/s001470050859
            development of functionally graded organ-specific   2.   Godown J, McKane M, Wujcik K, et al., 2016, Expanding the
            ECM based-bioinks will enable the bioprinting field to   donor pool: Regional variation in pediatric organ donation
            satisfy myriads of pragmatic biomedical applications,   rates. Pediatr Transplant, 20:1093–1097.
            such as the development of patient-specific tissue/organ   https://doi.org/10.1111/petr.12779
            equivalents with defined geometric arrangements and
            directed 3D bioassembly for personalized drug screening,   3.   Cippà PE, 2019, New ideas for old problems: How scientific
            liver reconstruction, and repair damaged tissue or whole   advances can change the future of organ transplantation.
            organ.                                                Transpl Intl, 32:561–562.
                                                                  https://doi.org/10.1111/tri.13419
            Acknowledgments                                    4.   Kitajima T, Kuno Y, Ivanics T, et al., 2022, Improved survival
            None.                                                 with higher-risk donor grafts in liver transplant with acute-
                                                                  on-chronic liver failure. Transplant Direct, 8:e1283.
            Funding                                               https://doi.org/10.1097/TXD.0000000000001283
            This work was primarily funded by KFSH&RC for      5.   Amin A, Panayotova G, Guarrera JV, 2022, Hypothermic
            Tissue and Organ Bioengineering Research Group        machine perfusion for liver graft preservation.  Curr Opin
            (RAC# 2150012). Any opinions, findings, conclusions,   Organ Transplant, 27:98–105.
            or  recommendations  expressed  herein  are  those  of  the   https://doi.org/10.1097/MOT.0000000000000973
            author(s) and do not necessarily reflect the views of the   6.   Kojima H, Yasuchika K, Fukumitsu K,  et al., 2018,
            KFSH&RC-Organ transplant Centre of excellence.        Establishment of practical recellularized liver graft for blood
                                                                  perfusion using primary rat hepatocytes and liver sinusoidal
            Conflict of interest                                  endothelial cells. Am J Transplant, 18:1351–1359.

            The authors declare no conflict of interest.          https://doi.org/10.1111/ajt.14666Citation



            Volume 9 Issue 3 (2023)                        351                          https://doi.org/10.18063/ijb.714
   354   355   356   357   358   359   360   361   362   363   364